Atrium Innovations.

ATB-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about ATB-T

Signal
Opinion
Expert
TOP PICK
TOP PICK
November 11, 2008
(A Top Pick Nov 9/07. Down 44%.) Health and nutrition supplements. Continuing to grow both revenue and profit line better than expected. Have the ability and cash to make acquisitions. (Recommends you do partial buys on a gradual basis.)
Show full opinionHide full opinion
Atrium Innovations. (ATB-T)
November 11, 2008
(A Top Pick Nov 9/07. Down 44%.) Health and nutrition supplements. Continuing to grow both revenue and profit line better than expected. Have the ability and cash to make acquisitions. (Recommends you do partial buys on a gradual basis.)
PAST TOP PICK
PAST TOP PICK
August 1, 2008
(A Top Pick Aug 3/07. Down 47%.) Great company. Made acquisitions and may have stretched itself. Doesn't think their market will be very strong over the next year.
Show full opinionHide full opinion
(A Top Pick Aug 3/07. Down 47%.) Great company. Made acquisitions and may have stretched itself. Doesn't think their market will be very strong over the next year.
PAST TOP PICK
PAST TOP PICK
July 21, 2008
(A Top Pick July 18/07. Down 51%.) Low price makes no sense as it is a better company now. Had just made a European acquisition, which gives them a very big position in the health area in Europe. Recently sold their active ingredient business for cash and will be concentrating on building their health and nutrition business in Europe and North America. Still a Buy.
Show full opinionHide full opinion
(A Top Pick July 18/07. Down 51%.) Low price makes no sense as it is a better company now. Had just made a European acquisition, which gives them a very big position in the health area in Europe. Recently sold their active ingredient business for cash and will be concentrating on building their health and nutrition business in Europe and North America. Still a Buy.
BUY
BUY
June 23, 2008
Sold a very profitable business so suddenly earnings forecasts dropped. Cash still has to be re-deployed. Stock is still very cheap, downside is very little $1.30 EPS this year $1.60 next year.
Show full opinionHide full opinion
Sold a very profitable business so suddenly earnings forecasts dropped. Cash still has to be re-deployed. Stock is still very cheap, downside is very little $1.30 EPS this year $1.60 next year.
PAST TOP PICK
PAST TOP PICK
June 13, 2008
(A Top Pick July 18/07. Down 38%.) Health and nutrition. Things have changed fundamentally for the better but the market hasn’t cared. Have a lot of cash from the sale of their active ingredient division. Buying for new accounts.
Show full opinionHide full opinion
(A Top Pick July 18/07. Down 38%.) Health and nutrition. Things have changed fundamentally for the better but the market hasn’t cared. Have a lot of cash from the sale of their active ingredient division. Buying for new accounts.
BUY
BUY
May 28, 2008
Biggest player in North America and a growing player in Europe in the health and nutrition business. Growing by acquisition and have a lot of cash for this.
Show full opinionHide full opinion
Biggest player in North America and a growing player in Europe in the health and nutrition business. Growing by acquisition and have a lot of cash for this.
BUY
BUY
May 27, 2008
Sold one of their businesses and is now focused on food supplements. Growth industry that generates a lot of free cash flow. Trade roughly 11X this year's free cash flow.
Show full opinionHide full opinion
Sold one of their businesses and is now focused on food supplements. Growth industry that generates a lot of free cash flow. Trade roughly 11X this year's free cash flow.
BUY
BUY
April 10, 2008
Health and nutrition. One of his favourite companies. Largest high quality manufacturer of vitamins and supplements sold through practitioners. Very profitable business. Selling their “active ingredient” business for $165 million. This had lower margins.
Show full opinionHide full opinion
Health and nutrition. One of his favourite companies. Largest high quality manufacturer of vitamins and supplements sold through practitioners. Very profitable business. Selling their “active ingredient” business for $165 million. This had lower margins.
TOP PICK
TOP PICK
March 24, 2008
They’ve announced they will sell a division. The division they’re keeping has high earnings. The stock is very close to the bottom.
Show full opinionHide full opinion
They’ve announced they will sell a division. The division they’re keeping has high earnings. The stock is very close to the bottom.
BUY
BUY
March 10, 2008
Biggest manufacturer of high quality vitamins and supplements sold directly through practitioners as opposed to health food and drug stores. Made some strategic acquisitions lately that have been accretive to earnings and will be great for long-term growth. Selling off their ingredient business and will use the proceeds for further acquisitions. Great name longer term.
Show full opinionHide full opinion
Biggest manufacturer of high quality vitamins and supplements sold directly through practitioners as opposed to health food and drug stores. Made some strategic acquisitions lately that have been accretive to earnings and will be great for long-term growth. Selling off their ingredient business and will use the proceeds for further acquisitions. Great name longer term.
BUY
BUY
February 12, 2008
Thought the stock was a great buy in the low $20's and at this price, it's even a better buy. Expectations of $1.60 in earnings for 08, which is all free cash flow. Right now the market is so bad for small caps this is the main reason for it coming down.
Show full opinionHide full opinion
Atrium Innovations. (ATB-T)
February 12, 2008
Thought the stock was a great buy in the low $20's and at this price, it's even a better buy. Expectations of $1.60 in earnings for 08, which is all free cash flow. Right now the market is so bad for small caps this is the main reason for it coming down.
TOP PICK
TOP PICK
January 3, 2008
A healthcare company. Sell food supplements. Grow by internal growth. Looking to make some acquisitions. Thinks they will make $1.40. This kind of stock could be worth 20X earnings.
Show full opinionHide full opinion
A healthcare company. Sell food supplements. Grow by internal growth. Looking to make some acquisitions. Thinks they will make $1.40. This kind of stock could be worth 20X earnings.
TOP PICK
TOP PICK
November 19, 2007
They sell high-end vitamins or food supplements in health stores. This should not be affected by the recession. Aging people will be willing to spend money for their health. Expect company to make $1.50 next year.
Show full opinionHide full opinion
Atrium Innovations. (ATB-T)
November 19, 2007
They sell high-end vitamins or food supplements in health stores. This should not be affected by the recession. Aging people will be willing to spend money for their health. Expect company to make $1.50 next year.
TOP PICK
TOP PICK
November 9, 2007
A Canadian multinational company. Manufacture vitamins and supplements. Acquired a German company that had a European painkiller, which they expect to expand into North America. Strong organic and earnings growth.
Show full opinionHide full opinion
A Canadian multinational company. Manufacture vitamins and supplements. Acquired a German company that had a European painkiller, which they expect to expand into North America. Strong organic and earnings growth.
TOP PICK
TOP PICK
October 9, 2007
Healthcare. Produce natural medications, not drugs. Just made a large acquisition in Europe, which is accretive. Good price. The only issue is that they report in US$.
Show full opinionHide full opinion
Healthcare. Produce natural medications, not drugs. Just made a large acquisition in Europe, which is accretive. Good price. The only issue is that they report in US$.
Showing 31 to 45 of 58 entries